Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CLDICalidi Biotherapeutics, Inc.

NYSE · CIK 0001855485
Filer category<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts300

Identity from submissions API

NameCalidi Biotherapeutics, Inc.
CIK0001855485
TickersCLDI, CLDWW
ExchangesNYSE, OTC
Entity typeoperating
Category<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN862967193
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone858-794-9600
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Calidi Biotherapeutics, Inc. (2023-09-25T00:00:00.000Z → 2026-11-13T00:00:00.000Z)
  • First Light Acquisition Group, Inc. (2021-05-17T00:00:00.000Z → 2023-09-19T00:00:00.000Z)
Business address
4475 EXECUTIVE DRIVE
SUITE 200
SAN DIEGO
CA
92121
CA
Mailing address
4475 EXECUTIVE DRIVE
SUITE 200
SAN DIEGO
CA
92121
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

408 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 10-Q 10-Q 0001193125-26-460940 001-40789 261553805 34 12855079 1 1
2026-11-13 8-K 8-K 2.02,7.01,9.01 0001193125-26-460816 001-40789 261553335 34 458859 1 1
2026-09-25 8-K 8-K 3.01,8.01,9.01 0001493152-26-044381 001-40789 261411242 34 231988 1 1
2026-09-22 8-K 8-K 1.01,8.01,9.01 0001493152-26-043724 001-40789 261397518 34 571968 1 1
2026-09-17 424B5 424B5 0001493152-26-043156 333-282456 261387596 33 383417
2026-08-19 4 4 0001493152-26-039292 6269
2026-08-19 4 4 0001493152-26-039290 6281
2026-08-19 4 4 0001493152-26-039291 6310
2026-08-19 4 4 0001493152-26-039289 6384
2026-08-19 4 4 0001493152-26-039288 6294
2026-08-19 4 4 0001493152-26-039287 6438
2026-08-19 4 4 0001493152-26-039286 16474
2026-08-19 4 4 0001493152-26-039285 6333
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003562 005-92875 261277050 34 10732
2026-08-13 10-Q 10-Q 0001493152-26-037847 001-40789 261274700 34 8573942 1 1
2026-08-13 8-K 8-K 2.02,7.01,9.01 0001493152-26-037840 001-40789 261274494 34 332890 1 1
2026-07-31 8-K 8-K 3.03,5.03,9.01 0001493152-26-035666 001-40789 261229354 34 232795 1 1
2026-07-16 8-K 8-K 1.01,1.02,2.03,9.01 0001493152-26-033594 001-40789 261181339 34 1712456 1 1
2026-06-29 3 3 0001493152-26-031118 14374
2026-06-23 8-K 8-K 5.02,7.01,8.01,9.01 0001493152-26-029710 001-40789 261109005 34 234032 1 1
2026-06-18 8-K 8-K 5.07 0001493152-26-029374 001-40789 261103840 34 220144 1 1
2026-06-05 DEFA14A DEFA14A 0001493152-26-027516 001-40789 261070042 34 21929
2026-05-29 8-K 8-K 1.01,3.02,9.01 0001493152-26-026415 001-40789 261045738 34 394298 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002136 005-92875 26984065 34 10557
2026-05-14 10-Q 10-Q 0001493152-26-023140 001-40789 26979872 34 8102193 1 1
2026-05-14 8-K 8-K 2.02,7.01,9.01 0001493152-26-023094 001-40789 26979148 34 311893 1 1
2026-05-08 8-K 8-K 1.01,3.02,9.01 0001493152-26-022024 001-40789 26959874 34 371360 1 1
2026-04-29 DEFA14A DEFA14A 0001493152-26-019636 001-40789 26917658 34 2020978
2026-04-29 DEF 14A DEF 14A 0001493152-26-019617 001-40789 26916902 34 2322424
2026-04-17 PRE 14A PRE 14A 0001493152-26-017935 001-40789 26872711 34 1331716 1 1
2026-04-02 8-K 8-K 5.02,8.01,9.01 0001493152-26-014951 001-40789 26835064 34 208419 1 1
2026-03-31 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0002109116-26-000004 005-92875 26823095 34 6817
2026-03-27 10-K 10-K 0001493152-26-013242 001-40789 26808340 34 15712796 1 1
2026-03-27 8-K 8-K 2.02,7.01,9.01 0001493152-26-013236 001-40789 26808286 34 283863 1 1
2026-03-11 8-K 8-K 1.01,3.02,8.01,9.01 0001493152-26-009701 001-40789 26744384 34 1757014 1 1
2026-03-09 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0002109116-26-000003 005-92875 26734103 34 6904
2026-03-09 424B5 424B5 0001493152-26-009239 333-284229 26732929 33 551977
2026-03-06 424B5 424B5 0001493152-26-009027 333-284229 26727774 33 565952
2026-03-05 S-3MEF S-3MEF 0001493152-26-009037 333-294074 26728356 33 279017 1 1
2026-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-005942 005-92875 26615053 34 6879
2026-02-10 8-K 8-K 7.01,9.01 0001493152-26-005840 001-40789 26613080 34 9655032 1 1
2026-02-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002109116-26-000002 005-92875 26597727 34 6451
2026-01-29 8-K 8-K 2.02,8.01,9.01 0001493152-26-004089 001-40789 26573907 34 299666 1 1
2025-12-16 4 4 0001493152-25-028030 6506
2025-11-13 10-Q 10-Q 0001493152-25-022372 001-40789 251479325 34 12228589 1 1
2025-11-13 8-K 8-K 2.02,7.01,9.01 0001493152-25-022349 001-40789 251479082 34 300253 1 1
2025-11-10 8-K 8-K 7.01,8.01,9.01 0001493152-25-021418 001-40789 251464548 34 10692172 1 1
2025-10-31 8-K 8-K 1.01,1.02,2.01,9.01 0001493152-25-020390 001-40789 251440723 34 442026 1 1
2025-10-24 8-K 8-K 7.01,8.01,9.01 0001493152-25-019353 001-40789 251416945 34 10680981 1 1
2025-09-19 8-K 8-K 1.01,5.02,9.01 0001493152-25-014293 001-40789 251327504 34 376229 1 1
2025-09-05 4 xslF345X05/ownership.xml 0001641172-25-026782 15852
2025-09-05 4 xslF345X05/ownership.xml 0001641172-25-026780 6123
2025-09-05 4 xslF345X05/ownership.xml 0001641172-25-026781 6084
2025-08-29 8-K 8-K 7.01,9.01 0001641172-25-026066 001-40789 251282095 34 7568378 1 1
2025-08-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-025645 005-92875 251260239 34 6914
2025-08-27 3 3 0001641172-25-025641 3985
2025-08-25 4 xslF345X05/ownership.xml 0001641172-25-025448 9571
2025-08-25 4 xslF345X05/ownership.xml 0001641172-25-025447 7468
2025-08-25 4 4 0001641172-25-025446 9201
2025-08-25 4 4 0001641172-25-025445 7369
2025-08-22 8-K 8-K 1.01,8.01,9.01 0001641172-25-025273 001-40789 251247272 34 283674 1 1
2025-08-21 424B4 424B4 0001641172-25-025041 333-289670 251238461 33 3930123
2025-08-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002698 333-289670 251238276 33 1899
2025-08-19 CORRESP filename1.htm 0001641172-25-024764 13315
2025-08-19 CORRESP filename1.htm 0001641172-25-024762 9461
2025-08-15 S-1 S-1 0001641172-25-024489 333-289670 251225689 33 22329562 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003581 005-92875 251222122 34 10734
2025-08-14 8-K 8-K 1.01,5.02,9.01 0001641172-25-024190 001-40789 251221059 34 280568 1 1
2025-08-08 10-Q 10-Q 0001641172-25-022797 001-40789 251199138 34 10634239 1 1
2025-08-08 8-K 8-K 2.02,7.01,9.01 0001641172-25-022791 001-40789 251199011 34 295794 1 1
2025-08-07 8-K 8-K 3.03,5.03,9.01 0001641172-25-022592 001-40789 251194688 34 232908 1 1
2025-07-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002362 333-288784 251152835 33 1899
2025-07-25 8-K 8-K 5.02,7.01,8.01,9.01 0001641172-25-021039 001-40789 251152276 34 257363 1 1
2025-07-24 CORRESP filename1.htm 0001641172-25-020815 12483
2025-07-22 UPLOAD filename1.pdf 0000000000-25-007712 333-288784 40182
2025-07-18 S-3 S-3 0001641172-25-020279 333-288784 251135202 33 647328 1 1
2025-07-15 4 xslF345X05/ownership.xml 0001641172-25-019802 6162
2025-07-15 4 xslF345X05/ownership.xml 0001641172-25-019803 6166
2025-07-15 4 xslF345X05/ownership.xml 0001641172-25-019801 6135
2025-07-15 4 xslF345X05/ownership.xml 0001641172-25-019800 6147
2025-07-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002240 333-288529 251120047 33 1899
2025-07-11 8-K 8-K 5.07 0001641172-25-018808 001-40789 251119619 34 244460 1 1
2025-07-10 CORRESP filename1.htm 0001641172-25-018566 13070
2025-07-10 424B3 424B3 0001641172-25-018557 333-283741 251115675 33 80146
2025-07-10 424B3 424B3 0001641172-25-018556 333-276741 251115674 33 121472
2025-07-10 8-K 8-K 1.01,3.02,7.01,9.01 0001641172-25-018553 001-40789 251115638 34 523911 1 1
2025-07-08 UPLOAD filename1.pdf 0000000000-25-007156 377-08171 40447
2025-07-08 UPLOAD filename1.pdf 0000000000-25-007155 333-288529 40183
2025-07-03 S-1 S-1 0001641172-25-017875 333-288529 251106446 33 18497473 1 1
2025-07-02 DRS filename1.htm 0001641172-25-017600 377-08171 251102488 33 4332999
2025-05-23 DEFA14A DEFA14A 0001641172-25-012253 001-40789 25981997 34 1738779
2025-05-23 DEF 14A DEF 14A 0001641172-25-012252 001-40789 25981956 34 2933652
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002220 005-92875 25951831 34 10550
2025-05-14 8-K 8-K 2.02,7.01,9.01 0001641172-25-010348 001-40789 25946866 34 272367 1 1
2025-05-14 10-Q 10-Q 0001641172-25-010317 001-40789 25946620 34 8582381 1 1
2025-05-12 PRE 14A PRE 14A 0001641172-25-009711 001-40789 25935318 34 1073532
2025-05-02 8-K 8-K 4.01,9.01 0001641172-25-008365 001-40789 25909084 34 280719 1 1
2025-04-25 4 xslF345X05/ownership.xml 0001641172-25-006070 16022
2025-04-25 3 xslF345X02/ownership.xml 0001641172-25-006062 3141
2025-04-23 8-K form8-k.htm 1.01,5.02,7.01,8.01,9.01 0001641172-25-005777 001-40789 25859268 34 677415 1 1
2025-04-10 8-K form8-k.htm 7.01,9.01 0001641172-25-003501 001-40789 25826332 34 290802 1 1
2025-04-01 8-K form8-k.htm 1.01,3.02,8.01,9.01 0001641172-25-001969 001-40789 25796389 34 1262870 1 1
2025-03-31 8-K form8-k.htm 2.02,7.01,9.01 0001641172-25-001822 001-40789 25794604 34 320932 1 1
2025-03-31 10-K form10-k.htm 0001641172-25-001810 001-40789 25794389 34 14843583 1 1
2025-03-31 424B5 form424b5.htm 0001641172-25-001350 333-284229 25788548 33 492583
2025-03-10 8-K form8-k.htm 7.01,9.01 0001493152-25-009731 001-40789 25724918 34 12292280 1 1
2025-02-10 8-K/A form8-ka.htm 9.01 0001493152-25-005699 001-40789 25606790 34 220072 1 1
2025-02-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000352 333-284229 25603473 33 1905
2025-02-06 CORRESP filename1.htm 0001493152-25-005084 13330
2025-02-05 424B5 form424b5.htm 0001493152-25-004885 333-282456 25590753 33 22403
2025-02-05 8-K form8-k.htm 8.01,9.01 0001493152-25-004887 001-40789 25590033 34 256576 1 1
2025-01-28 8-K form8-k.htm 1.02,2.02,7.01,9.01 0001493152-25-003916 001-40789 25561063 34 259593 1 1
2025-01-15 UPLOAD filename1.pdf 0000000000-25-000432 333-284229 40187
2025-01-10 S-3 forms-3.htm 0001493152-25-001755 333-284229 25523739 33 425718
2025-01-10 8-K form8-k.htm 8.01,9.01 0001493152-25-001711 001-40789 25523324 34 220875 1 1
2025-01-10 8-K form8-k.htm 1.01,3.02,7.01,8.01,9.01 0001493152-25-001567 001-40789 25520581 34 46507099 1 1
2025-01-10 424B5 form424b5.htm 0001493152-25-001565 333-282456 25520574 33 464061
2025-01-08 424B5 form424b5.htm 0001493152-25-001382 333-282456 25518515 33 492940
2025-01-03 4 xslF345X05/ownership.xml 0001493152-25-000306 5653
2025-01-03 4 xslF345X05/ownership.xml 0001493152-25-000302 5634
2024-12-27 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-24-003933 333-283741 241586819 33 1906
2024-12-26 CORRESP filename1.htm 0001493152-24-052065 12810
2024-12-18 4 xslF345X05/ownership.xml 0001493152-24-050675 6142
2024-12-17 UPLOAD filename1.pdf 0000000000-24-013920 333-283741 40240
2024-12-12 S-1 forms-1.htm 0001493152-24-049670 333-283741 241543158 33 24852693 1 1
2024-11-29 424B5 form424b5.htm 0001493152-24-048189 333-282456 241516820 33 48621
2024-11-18 8-K form8-k.htm 7.01,9.01 0001493152-24-046434 001-40789 241469803 34 304442 1 1
2024-11-15 8-K form8-k.htm 1.01,3.02,8.01,9.01 0001493152-24-046330 001-40789 241468763 34 684260 1 1
2024-11-15 424B5 form424b5.htm 0001493152-24-046144 333-282456 241465734 33 447515
2024-11-14 SC 13G/A CALIDI BIOTHERAPEUTICS, INC. 0001326389-24-000189 005-92875 241460198 34 7057
2024-11-14 424B5 form424b5.htm 0001493152-24-045268 333-282456 241456912 33 480695
2024-11-13 8-K form8-k.htm 2.02,7.01,9.01 0001493152-24-044932 001-40789 241450760 34 323496 1 1
2024-11-12 10-Q form10-q.htm 0001493152-24-044833 001-40789 241449750 34 12209269 1 1
2024-10-28 25-NSE xslF25X02/primary_doc.xml 0001143313-24-000107 001-40789 241399106 34 5162
2024-10-24 8-K form8-k.htm 1.01,3.02,8.01,9.01 0001493152-24-042406 001-40789 241393481 34 1250130 1 1
2024-10-24 424B5 form424b5.htm 0001493152-24-042327 333-282456 241390965 33 480768
2024-10-23 424B5 form424b5.htm 0001493152-24-042171 333-282456 241387860 33 43395
2024-10-18 8-K form8-k.htm 7.01,9.01 0001493152-24-041633 001-40789 241381543 34 41319228 1 1
2024-10-18 8-K form8-k.htm 3.01,7.01,9.01 0001493152-24-041623 001-40789 241381522 34 287572 1 1
2024-10-15 4 xslF345X05/ownership.xml 0001493152-24-041199 6155
2024-10-15 4 xslF345X05/ownership.xml 0001493152-24-041200 6143
2024-10-15 4 xslF345X05/ownership.xml 0001493152-24-041201 6170
2024-10-15 4 xslF345X05/ownership.xml 0001493152-24-041202 6174
2024-10-11 424B5 form424b5.htm 0001493152-24-040963 333-282456 241368288 33 394667
2024-10-11 8-K form8-k.htm 1.01,9.01 0001493152-24-040953 001-40789 241368168 34 625198 1 1
2024-10-10 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-10-10 17:00:00 9999999995-24-003157 333-282456 241366243 33 1906
2024-10-08 CORRESP filename1.htm 0001493152-24-040408 9993
2024-10-07 S-3/A forms-3a.htm 0001493152-24-040295 333-282456 241358191 33 277110
2024-10-07 UPLOAD filename1.pdf 0000000000-24-011274 333-282456 40211
2024-10-01 S-3 forms-3.htm 0001493152-24-039049 333-282456 241344219 33 338291
2024-10-01 S-8 forms-8.htm 0001493152-24-039045 333-282455 241344150 33 809454
2024-09-30 4 xslF345X05/ownership.xml 0001493152-24-038877 6076
2024-09-30 8-K form8-k.htm 7.01,9.01 0001493152-24-038718 001-40789 241336950 34 312709 1 1
2024-09-24 8-K form8-k.htm 5.07 0001493152-24-037858 001-40789 241317233 34 278760 1 1
2024-09-12 8-K form8-k.htm 7.01,9.01 0001493152-24-035939 001-40789 241293827 34 5420709 1 1
2024-09-11 SC 13G cldi.htm 0001937147-24-000008 005-92875 241292613 34 103983
2024-08-22 8-K form8-k.htm 7.01,9.01 0001493152-24-033579 001-40789 241232807 34 37132485 1 1
2024-08-20 8-K form8-k.htm 5.02,8.01 0001493152-24-033215 001-40789 241222533 34 263005 1 1
2024-08-20 DEF 14A formdef14a.htm 0001493152-24-033186 001-40789 241222030 34 754802
2024-08-14 8-K form8-k.htm 2.02,7.01,9.01 0001493152-24-031718 001-40789 241203310 34 349165 1 1
2024-08-13 10-Q form10-q.htm 0001493152-24-031688 001-40789 241202887 34 11081016 1 1
2024-07-29 8-K form8-k.htm 1.01,3.02,7.01,9.01 0001493152-24-029384 001-40789 241149207 34 5726177 1 1
2024-07-15 8-K form8-k.htm 5.03,9.01 0001493152-24-027867 001-40789 241117895 34 1121062 1 1
2024-07-11 4 xslF345X05/ownership.xml 0001493152-24-026971 5948
2024-07-11 3 xslF345X02/ownership.xml 0001493152-24-026969 457466
2024-07-08 8-K form8-k.htm 1.01,2.03,9.01 0001493152-24-026477 001-40789 241105077 34 4335784 1 1
2024-07-05 8-K form8-k.htm 7.01,9.01 0001493152-24-026374 001-40789 241102875 34 287711 1 1
2024-07-02 4 xslF345X05/ownership.xml 0001493152-24-026117 5461
2024-07-02 4 xslF345X05/ownership.xml 0001493152-24-026115 5476
2024-07-02 4 xslF345X05/ownership.xml 0001493152-24-026113 5480
2024-07-02 4 xslF345X05/ownership.xml 0001493152-24-026111 565223
2024-07-02 4 xslF345X05/ownership.xml 0001493152-24-026108 5475
2024-07-02 4 xslF345X05/ownership.xml 0001493152-24-026105 496362
2024-06-26 8-K form8-k.htm 5.02,9.01 0001493152-24-025267 001-40789 241073618 34 267105 1 1
2024-06-20 4 xslF345X05/ownership.xml 0001493152-24-024597 536273
2024-06-20 4 xslF345X05/ownership.xml 0001493152-24-024600 21438
2024-06-20 4 xslF345X05/ownership.xml 0001493152-24-024598 51308
2024-06-20 4 xslF345X05/ownership.xml 0001493152-24-024599 6090
2024-06-12 8-K form8-k.htm 5.07,9.01 0001493152-24-023520 001-40789 241037159 34 301434 1 1
2024-06-06 D xslFormDX01/primary_doc.xml 06b 0001855485-24-000006 021-515263 241023307 33 13322
2024-06-05 4 xslF345X05/ownership.xml 0001493152-24-022745 22150
2024-06-04 424B3 form424b3.htm 0001493152-24-022591 333-276741 241019555 33 153501
2024-06-04 8-K form8-k.htm 1.01,3.02,9.01 0001493152-24-022572 001-40789 241019142 34 433388 1 1
2024-05-31 8-K form8-k.htm 1.01,3.02,7.01,9.01 0001493152-24-022229 001-40789 241010661 34 569788 1 1
2024-05-17 8-K form8-k.htm 5.02,9.01 0001493152-24-020443 001-40789 24960430 34 269906 1 1
2024-05-16 424B3 form424b3.htm 0001493152-24-020315 333-276741 24956878 33 1075535
2024-05-16 8-K form8-k.htm 5.02 0001493152-24-020222 001-40789 24955365 34 263558 1 1
2024-05-15 8-K form8-k.htm 2.02,7.01,9.01 0001493152-24-019358 001-40789 24946752 34 336167 1 1
2024-05-14 10-Q form10-q.htm 0001493152-24-019305 001-40789 24945438 34 8943814 1 1
2024-05-09 DEF 14A formdef14a.htm 0001493152-24-018494 001-40789 24931698 34 1545947
2024-05-01 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0002021677-24-000001 005-92875 24901843 34 6081
2024-04-29 PRE 14A formpre14a.htm 0001493152-24-017034 001-40789 24892278 34 1065877
2024-04-22 4 xslF345X05/ownership.xml 0001493152-24-015572 27155
2024-04-19 8-K form8-k.htm 7.01,9.01 0001493152-24-015397 001-40789 24858997 34 14581377 1 1
2024-04-19 8-K form8-k.htm 1.01,7.01,8.01,9.01 0001493152-24-015390 001-40789 24858948 34 364332 1 1
2024-04-18 8-K form8-k.htm 1.01,9.01 0001493152-24-015220 001-40789 24854920 34 268906 1 1
2024-04-17 424B4 form424b4.htm 0001493152-24-015035 333-276741 24851259 33 3256673
2024-04-15 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-04-15 17:30:00 9999999995-24-000978 333-276741 24849286 33 1905
2024-04-15 CORRESP filename1.htm 0001493152-24-014568 17301
2024-04-15 CORRESP filename1.htm 0001493152-24-014542 13850
2024-04-15 CORRESP filename1.htm 0001493152-24-014541 30961
2024-04-15 S-1/A forms-1a.htm 0001493152-24-014529 333-276741 24843064 33 17221346 1 1
2024-04-10 CORRESP filename1.htm 0001493152-24-014140 29799
2024-04-10 CORRESP filename1.htm 0001493152-24-014139 13438
2024-04-08 S-1/A forms-1a.htm 0001493152-24-013794 333-276741 24830099 33 17159464 1 1
2024-04-02 S-1/A forms-1a.htm 0001493152-24-012869 333-276741 24815809 33 459167
2024-04-01 8-K form8-k.htm 1.01,9.01 0001493152-24-012176 001-40789 24805807 34 343265 1 1
2024-04-01 S-1/A forms-1a.htm 0001493152-24-012083 333-276741 24805318 33 17562712 1 1
2024-03-21 D xslFormDX01/primary_doc.xml 06b 0001855485-24-000005 021-508167 24768819 33 12444
2024-03-21 D xslFormDX01/primary_doc.xml 06b 0001855485-24-000004 021-508166 24768776 33 12833
2024-03-21 D xslFormDX01/primary_doc.xml 06b 0001855485-24-000003 021-508162 24768747 33 12475
2024-03-21 D xslFormDX01/primary_doc.xml 06b 0001855485-24-000002 021-508161 24768726 33 12477
2024-03-21 D xslFormDX01/primary_doc.xml 06b 0001855485-24-000001 021-508160 24768708 33 12821
2024-03-18 8-K form8-k.htm 2.02,7.01,9.01 0001493152-24-010208 001-40789 24757021 34 346873 1 1
2024-03-15 10-K form10-k.htm 0001493152-24-010158 001-40789 24756123 34 15178961 1 1
2024-03-12 3 xslF345X02/ownership.xml 0001493152-24-009741 14814
2024-03-12 424B3 form424b3.htm 0001493152-24-009695 333-274885 24743546 33 67974
2024-03-12 8-K form8-k.htm 1.01,1.02,2.03,3.02,9.01 0001493152-24-009678 001-40789 24742965 34 656777 1 1
2024-03-01 424B3 form424b3.htm 0001493152-24-008606 333-274885 24711750 33 60061
2024-03-01 8-K form8-k.htm 5.03,9.01 0001493152-24-008601 001-40789 24711706 34 282734 1 1
2024-02-28 8-K form8-k.htm 7.01,9.01 0001493152-24-008203 001-40789 24696257 34 9179466 1 1
2024-02-14 SC 13G/A 683 CAPITAL MANAGEMENT, LLC 0001085146-24-001429 005-92875 24637562 34 45179
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-034765 005-92875 24631861 34 57538
2024-02-12 SC 13G/A schedule13gaflag021224.htm 0001604488-24-000031 005-92875 24621516 34 79780
2024-02-12 SC 13G/A CALIDI BIOTHERAPEUTICS, INC. 0000902664-24-001433 005-92875 24620540 34 46402
2024-02-12 424B3 form424b3.htm 0001493152-24-005810 333-274885 24617311 33 57311
2024-02-12 8-K form8-k.htm 3.02,8.01,9.01 0001493152-24-005808 001-40789 24617307 34 267791 1 1
2024-02-09 SC 13G/A SC 13G/A 0001193125-24-030256 005-92875 24615980 34 51308
2024-02-09 SC 13G/A CALIDI BIOTHERAPEUTICS INC 13GA 0001326389-24-000014 005-92875 24611107 34 7573
2024-02-07 8-K form8-k.htm 2.02,7.01 0001493152-24-005220 001-40789 24603442 34 266454 1 1
2024-02-07 S-1/A forms-1a.htm 0001493152-24-005218 333-276741 24603262 33 22671199 1 1
2024-02-01 424B3 form424b3.htm 0001493152-24-004624 333-274885 24587860 33 58239
2024-02-01 8-K form8-k.htm 1.01,2.03,3.02,9.01 0001493152-24-004619 001-40789 24587769 34 515605 1 1
2024-02-01 UPLOAD filename1.pdf 0000000000-24-001249 333-276741 40465
2024-01-29 S-1 forms-1.htm 0001493152-24-004091 333-276741 24570827 33 23405596 1 1
2024-01-23 424B3 form424b3.htm 0001493152-24-003474 333-274885 24553297 33 4638905
2024-01-19 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-01-19 17:00:00 9999999995-24-000156 333-274885 24546964 33 1905
2024-01-17 CORRESP filename1.htm 0001493152-24-002665 31350
2024-01-16 CORRESP filename1.htm 0001493152-24-002329 86532
2024-01-16 S-1/A forms-1a.htm 0001493152-24-002327 333-274885 24533581 33 22594763 1 1
2024-01-10 UPLOAD filename1.pdf 0000000000-24-000356 333-274885 44095
2024-01-08 8-K form8-k.htm 7.01,9.01 0001493152-24-001661 001-40789 24518392 34 292442 1 1
2024-01-08 S-1/A forms-1a.htm 0001493152-24-001656 333-274885 24518228 33 22807120 1 1
2024-01-08 CORRESP filename1.htm 0001493152-24-001655 46446
2024-01-05 8-K form8-k.htm 7.01,9.01 0001493152-24-001163 001-40789 24514466 34 14404868 1 1
2024-01-04 4 xslF345X05/ownership.xml 0001493152-24-001138 5460
2024-01-04 4 xslF345X05/ownership.xml 0001493152-24-001136 16488
2024-01-04 4 xslF345X05/ownership.xml 0001493152-24-001134 8193
2024-01-04 4 xslF345X05/ownership.xml 0001493152-24-001132 8198
2024-01-04 4 xslF345X05/ownership.xml 0001493152-24-001131 6419
2023-12-26 4 xslF345X05/ownership.xml 0001493152-23-046173 5408
2023-12-21 UPLOAD filename1.pdf 0000000000-23-013976 333-274885 49285
2023-12-19 8-K form8-k.htm 7.01 0001493152-23-045437 001-40789 231498248 34 8174349 1 1
2023-12-12 CORRESP filename1.htm 0001493152-23-044606 59105
2023-12-12 S-1/A forms-1a.htm 0001493152-23-044602 333-274885 231482135 33 22785853 1 1
2023-12-12 8-K form8-k.htm 1.01,3.02,5.02,9.01 0001493152-23-044598 001-40789 231482084 34 637701 1 1
2023-12-05 8-K form8-k.htm 5.02 0001493152-23-043727 001-40789 231467417 34 267443 1 1
2023-11-14 8-K form8-k.htm 2.02,7.01,9.01 0001493152-23-041223 001-40789 231407509 34 344176 1 1
2023-11-14 10-Q form10-q.htm 0001493152-23-041122 001-40789 231406519 34 12220462 1 1
2023-11-02 3 xslF345X02/ownership.xml 0001493152-23-039102 3036
2023-10-30 8-K form8-k.htm 1.01,5.02,7.01,9.01 0001493152-23-038596 001-40789 231357142 34 402256 1 1
2023-10-27 8-K form8-k.htm 5.02,9.01 0001493152-23-038547 001-40789 231356219 34 267712 1 1
2023-10-26 4 xslF345X05/ownership.xml 0001493152-23-038346 3413
2023-10-25 3 xslF345X02/ownership.xml 0001493152-23-038292 7272
2023-10-24 8-K/A form8-ka.htm 5.02,9.01 0001493152-23-038156 001-40789 231343406 34 277156 1 1
2023-10-19 UPLOAD filename1.pdf 0000000000-23-011445 333-274885 56570
2023-10-16 8-K form8-k.htm 5.02 0001493152-23-037376 001-40789 231327802 34 262575 1 1
2023-10-10 SC 13G/A FLAG 13G/A 0001393825-23-000227 005-92875 231317371 34 54627
2023-10-06 S-1 forms-1.htm 0001493152-23-036426 333-274885 231312466 33 28824894 1 1
2023-10-02 SC 13D/A AMENDMENT NO. 3 TO SCHEDULE 13D 0001213900-23-081142 005-92875 231297182 34 66908
2023-09-26 SC 13D formsc13d.htm 0001493152-23-033652 005-92875 231276888 34 203676
2023-09-26 SC 13D formsc13d.htm 0001493152-23-033651 005-92875 231276887 34 168052
2023-09-25 3 xslF345X02/ownership.xml 0001493152-23-033648 23163
2023-09-25 3 xslF345X02/ownership.xml 0001493152-23-033641 25552
2023-09-25 3 xslF345X02/ownership.xml 0001493152-23-033646 20573
2023-09-25 3 xslF345X02/ownership.xml 0001493152-23-033639 23361
2023-09-25 3 xslF345X02/ownership.xml 0001493152-23-033640 24039
2023-09-25 3 xslF345X02/ownership.xml 0001493152-23-033642 29816
2023-09-25 3 xslF345X02/ownership.xml 0001493152-23-033645 20356
2023-09-25 3 xslF345X02/ownership.xml 0001493152-23-033647 26042
2023-09-25 3 xslF345X02/ownership.xml 0001493152-23-033643 26940
2023-09-25 3 xslF345X02/ownership.xml 0001493152-23-033644 29846
2023-09-25 3 xslF345X02/ownership.xml 0001493152-23-033638 25308
2023-09-25 3 xslF345X02/ownership.xml 0001493152-23-033637 70878
2023-09-19 8-K 8-K 1.01,2.01,3.03,4.01,5.01,5.02,5.03,5.05,5.06,9.01 0001193125-23-237077 001-40789 231262234 34 3137960 1 1
2023-09-14 4 FORM 4 SUBMISSION 0000899243-23-019095 25495
2023-09-14 4 FORM 4 SUBMISSION 0000899243-23-019094 14349
2023-09-14 4 PRIMARY DOCUMENT 0001393825-23-000222 7767
2023-09-13 25-NSE xslF25X02/primary_doc.xml 0001143313-23-000063 001-40789 231252272 34 4325
2023-09-11 8-K 8-K 8.01,9.01 0001193125-23-232609 001-40789 231248545 34 222629 1 1
2023-09-08 SC 13G SCHEDULE 13G 0001213900-23-075389 005-92875 231245354 34 94134
2023-09-08 SC 13G meteora_flag083123.htm 0001172661-23-003234 005-92875 231244954 34 84921
2023-08-31 8-K 8-K 1.01,9.01 0001193125-23-225571 001-40789 231227109 34 1868594 1 1
2023-08-29 8-K 8-K 1.01,5.07,8.01,9.01 0001193125-23-222968 001-40789 231218034 34 794946 1 1
2023-08-24 425 425 0001193125-23-220130 001-40789 231202381 34 42011
2023-08-24 8-K 8-K 8.01,9.01 0001193125-23-220122 001-40789 231202335 34 230861 1 1
2023-08-22 425 425 0001193125-23-218009 001-40789 231193705 34 41748
2023-08-22 8-K 8-K 8.01,9.01 0001193125-23-218005 001-40789 231193626 34 230600 1 1
2023-08-21 10-Q 10-Q 0001193125-23-217072 001-40789 231190036 34 6150810 1 1
2023-08-21 425 425 0001193125-23-216407 001-40789 231187205 34 27809
2023-08-21 8-K 8-K 8.01 0001193125-23-216394 001-40789 231187189 34 210106 1 1
2023-08-16 425 425 0001193125-23-213871 001-40789 231176503 34 23939917
2023-08-16 8-K 8-K 7.01,9.01 0001193125-23-213869 001-40789 231176502 34 24155863 1 1
2023-08-15 NT 10-Q NT 10-Q 0001193125-23-213443 001-40789 231174940 34 24664
2023-08-08 SEC STAFF LETTER filename1.pdf 9999999997-23-003749 63564
2023-08-07 425 425 0001193125-23-205022 001-40789 231147996 34 35044
2023-08-04 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2023-08-04 12:00:00 9999999995-23-002280 333-269705 231145475 33 1725
2023-08-04 424B3 424B3 0001193125-23-203650 333-269705 231143037 33 7491746
2023-08-03 CORRESP filename1.htm 0001193125-23-202736 9474
2023-08-02 S-4/A S-4/A 0001193125-23-201774 333-269705 231136552 33 97547
2023-08-01 S-4/A S-4/A 0001193125-23-200665 333-269705 231132816 33 17734774 1 1
2023-07-26 SEC STAFF LETTER filename1.pdf 9999999997-23-003682 65065
2023-07-25 S-4/A S-4/A 0001193125-23-192507 333-269705 231106196 33 18602294 1 1
2023-07-24 CORRESP filename1.htm 0001193125-23-192508 34933
2023-07-18 425 425 0001193125-23-188507 001-40789 231093049 34 38210
2023-07-14 UPLOAD filename1.pdf 0000000000-23-007543 46770
2023-07-03 S-4/A S-4/A 0001193125-23-180782 333-269705 231063341 33 18124437 1 1
2023-06-30 CORRESP filename1.htm 0001193125-23-180784 34963
2023-06-28 SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D 0001213900-23-052220 005-92875 231048710 34 124876
2023-06-23 425 425 0001193125-23-173154 001-40789 231034876 34 112503
2023-06-23 8-K 8-K 1.01,7.01,9.01 0001193125-23-173151 001-40789 231034873 34 316121 1 1
2023-06-16 8-K 8-K 8.01 0001193125-23-169071 001-40789 231021916 34 195841 1 1
2023-05-18 UPLOAD filename1.pdf 0000000000-23-005298 45997
2023-05-15 10-Q 10-Q 0001193125-23-145095 001-40789 23923369 34 5027546 1 1
2023-05-09 S-4/A S-4/A 0001193125-23-138552 333-269705 23899587 33 13782296 1 1
2023-05-08 CORRESP filename1.htm 0001193125-23-138555 43447
2023-04-28 UPLOAD filename1.pdf 0000000000-23-004394 52388
2023-04-13 CORRESP filename1.htm 0001193125-23-100736 79534
2023-04-13 S-4/A S-4/A 0001193125-23-100731 333-269705 23819257 33 14453867 1 1
2023-04-13 425 425 0001193125-23-100730 001-40789 23819216 34 42487
2023-04-13 8-K 8-K 1.01,9.01 0001193125-23-100724 001-40789 23819198 34 229574 1 1
2023-03-31 10-K 10-K 0001193125-23-088349 001-40789 23789177 34 7033417 1 1
2023-03-09 UPLOAD filename1.pdf 0000000000-23-002316 77496
2023-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0001013594-23-000215 005-92875 23626929 34 72120
2023-02-14 SC 13G FLAG 13G 0001604488-23-000049 005-92875 23625542 34 79736
2023-02-13 SC 13G/A flag13ga.htm 0000935836-23-000144 005-92875 23615787 34 61665
2023-02-10 SC 13G/A SC 13G/A 0001193125-23-032889 005-92875 23613535 34 62148
2023-02-10 S-4 FORM S-4 0001193125-23-032781 333-269705 23612972 33 16158668 1 1
2023-02-10 425 425 0001193125-23-032755 001-40789 23612869 34 14196860
2023-02-10 8-K 8-K 1.01,7.01,9.01 0001193125-23-032729 001-40789 23612798 34 14405531 1 1
2023-02-10 SC 13G/A FIRST LIGHT ACQUISITION GROUP, INC. 0000902664-23-001475 005-92875 23611872 34 50857
2023-02-10 SC 13G/A FLAG 0001326389-23-000542 005-92875 23607831 34 6873
2023-02-06 SC 13G BANK OF MONTREAL 0001085146-23-000659 005-92875 23589564 34 47849
2023-01-25 SC 13G/A FIRST LIGHT ACQUISITION GROUP, INC. 0000902664-23-000652 005-92875 23550587 34 50070
2023-01-09 425 425 0001193125-23-004709 001-40789 23517991 34 16059074
2023-01-09 8-K 8-K 1.01,7.01,9.01 0001193125-23-004705 001-40789 23517976 34 16472569 1 1
2022-12-27 8-K 8-K 5.02 0001193125-22-311947 001-40789 221486681 34 198019 1 1
2022-12-16 SC 13D/A SC 13D/A 0001140361-22-045742 005-92875 221466171 34 100524
2022-12-15 8-K 8-K 8.01,9.01 0001193125-22-305908 001-40789 221465012 34 203387 1 1
2022-11-25 25 25 0001193125-22-292507 001-40789 221419353 34 16373
2022-11-14 CERT NYSE AMERICAN CERTIFICATION 0001143362-22-000360 001-40789 221383728 34 529915
2022-11-14 8-A12B 8-A12B 0001193125-22-284111 001-40789 221382336 34 15964
2022-11-14 8-K 8-K 3.01,7.01,9.01 0001193125-22-283885 001-40789 221381043 34 203144 1 1
2022-11-14 10-Q 10-Q 0001193125-22-282874 001-40789 221379176 34 5556666 1 1
2022-11-08 SC 13G FLAG 13G 0001393825-22-000219 005-92875 221368850 34 58878
2022-10-27 SC 13G SC 13G 0001193125-22-270964 005-92875 221337398 34 65765
2022-10-21 4 PRIMARY DOCUMENT 0001326389-22-000013 5746
2022-10-18 SC 13G/A SC 13G/A 0001104659-22-109737 005-92875 221316605 34 352664
2022-10-14 3 PRIMARY DOCUMENT 0001393825-22-000216 4860
2022-10-13 SC 13G/A NONE 0001567619-22-018478 005-92875 221308714 34 125629
2022-10-11 SC 13G/A NONE 0001567619-22-018382 005-92875 221302505 34 121175
2022-09-26 3 PRIMARY DOCUMENT 0001326389-22-000010 5069
2022-09-21 SC 13D SC 13D 0001140361-22-034298 005-92875 221257299 34 175039
2022-09-16 8-K 8-K 1.01,2.03,5.02,5.03,5.07,7.01,9.01 0001193125-22-246494 001-40789 221248786 34 347025 1 1
2022-09-14 4 FORM 4 SUBMISSION 0000899243-22-031083 10030
2022-09-09 8-K 8-K 8.01,9.01 0001193125-22-242078 001-40789 221236882 34 205488 1 1
2022-08-23 DEF 14A DEF 14A 0001193125-22-227350 001-40789 221186251 34 920623
2022-08-16 UPLOAD filename1.pdf 0000000000-22-008720 39797
2022-08-15 CORRESP filename1.htm 0001193125-22-221376 26683
2022-08-12 UPLOAD filename1.pdf 0000000000-22-008608 44863
2022-08-10 10-Q 10-Q 0001193125-22-216531 001-40789 221150200 34 4750505 1 1
2022-08-08 PRE 14A PRE 14A 0001193125-22-215027 001-40789 221145355 34 197079
2022-05-11 10-Q 10-Q 0001193125-22-146662 001-40789 22911884 34 4013389 1 1
2022-03-31 10-K FORM 10-K 0001193125-22-090215 001-40789 22788613 34 5799779 1 1
2022-02-14 SC 13G flag13g.htm 0000935836-22-000159 005-92875 22629889 34 61351
2022-02-14 SC 13G NONE 0001567619-22-003838 005-92875 22626197 34 66375
2022-02-14 SC 13G/A AMENDMENT NO. 1 0000950142-22-000651 005-92875 22625465 34 91068
2022-02-11 SC 13G FIRST LIGHT ACQUISITION GROUP, INC. 0000902664-22-001495 005-92875 22616704 34 50188
2022-02-11 SC 13G SC 13G 0001193125-22-035546 005-92875 22616536 34 68785
2022-02-08 SC 13G FORM SC 13G 0001062993-22-003002 005-92875 22599741 34 32182
2022-02-03 SC 13G/A FIRST LIGHT ACQUISITION GROUP, INC. 0000902664-22-001021 005-92875 22586649 34 47858
2021-11-12 10-Q FORM 10-Q 0001193125-21-328181 001-40789 211404243 34 3959241 1 1
2021-10-28 8-K 8-K 8.01,9.01 0001193125-21-311401 001-40789 211358996 34 28047
2021-10-26 SC 13G firstlight13g-102621.htm 0001013594-21-000785 005-92875 211348900 34 84307
2021-09-24 SC 13G SC 13G 0001104659-21-119294 005-92875 211277355 34 387056
2021-09-24 SC 13G FIRST LIGHT ACQUISITION GROUP, INC. 0000902664-21-004327 005-92875 211274149 34 51651
2021-09-24 SC 13G SCHEDULE 13G 0000950142-21-002980 005-92875 211274070 34 90852
2021-09-20 8-K 8-K 8.01,9.01 0001193125-21-277439 001-40789 211264141 34 132607
2021-09-15 8-K 8-K 8.01,9.01 0001193125-21-273980 001-40789 211255610 34 1652232
2021-09-14 3/A FORM 3/A 0001140361-21-031284 42001
2021-09-13 424B4 424B4 0001193125-21-271636 333-259038 211250422 33 1781331
2021-09-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-09-09 16:00:00 9999999995-21-003461 333-259038 211245746 33 1691
2021-09-09 3 FORM 3 0001140361-21-030861 9788
2021-09-09 3 FORM 3 0001140361-21-030860 9333
2021-09-09 3 FORM 3 0001140361-21-030859 9382
2021-09-09 3 FORM 3 0001140361-21-030858 41151
2021-09-09 3 FORM 3 0001140361-21-030857 9376
2021-09-09 3 FORM 3 0001140361-21-030856 10643
2021-09-09 CERT NYSE CERTIFICATION 0000876661-21-001291 001-40789 211244000 34 671760
2021-09-09 8-A12B 8-A12B 0001193125-21-268555 001-40789 211243839 34 20481

Latest XBRL company facts

One latest value per concept from companyfacts (300 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 3.45M 2026-11-11 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
dei EntityPublicFloat Entity Public Float USD 8.00M 2025-06-30 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 1.52M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 487,324 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 870 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 5.79M 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 19,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-041122
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.84M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -35,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 154.31M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD 2.68M 2023-04-01 2023-06-30 2023 Q3 10-Q 2023-11-14 0001493152-23-041122
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 62,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 2.68M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 158,000 2024-01-01 2024-03-31 2025 Q3 10-Q 2025-11-13 0001493152-25-022372
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 450,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 45,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap Assets Assets USD 5.52M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap AssetsCurrent Assets, Current USD 4.74M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 219,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023140
us-gaap AssetsHeldInTrust Assets Held-in-trust USD 41.68M 2022-09-19 2022 FY 10-K 2023-03-31 0001193125-23-088349
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 43.21M 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap AssetsNoncurrent Assets, Noncurrent USD 43.21M 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 26,000 2023-01-01 2023-06-30 2024 Q2 10-Q 2024-08-13 0001493152-24-031688
us-gaap Cash Cash USD 3.95M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 9.60M 2024-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 218,000 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -465,131 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-11 0001193125-22-146662
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 4.17M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -1.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations USD 1.58M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 1.14 2024-09-04 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.86M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 58,235 2024-07-26 2025 Q2 10-Q 2025-08-08 0001641172-25-022797
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 330.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 2.89M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 2.89M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023140
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -11.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -11.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 1.86M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap ConvertibleDebt Convertible Debt USD 0 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 1.15M 2022-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 1.77M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001493152-24-044833
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 1.02M 2024-03-31 2024 Q1 10-Q 2024-05-14 0001493152-24-019305
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 266,104 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001193125-23-088349
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 14,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 15,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 700,000 2025-01-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 668,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap DebtInstrumentConvertibleConversionRatio1 Debt Instrument, Convertible, Conversion Ratio pure 0.42 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 3.00M 2024-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 821,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.24 2024-06-30 2024 Q2 10-Q 2024-08-13 0001493152-24-031688
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 21,000 2023-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap DebtInstrumentUnamortizedDiscountCurrent Debt Instrument, Unamortized Discount, Current USD 128,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001493152-24-044833
us-gaap DebtWeightedAverageInterestRate Debt, Weighted Average Interest Rate pure 0.15 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 1.60M 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -921,893 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001193125-23-088349
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 480,000 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -208,085 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001193125-23-088349
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 0 2022-12-31 2022 FY 10-K 2023-03-31 0001193125-23-088349
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 34.70M 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2022-12-31 2022 FY 10-K 2023-03-31 0001193125-23-088349
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 25.92M 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 928,000 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.35M 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 178,000 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 34.22M 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs USD 17.60M 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap Depreciation Depreciation USD 91,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001641172-25-010317
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap DerivativeAssetsNoncurrent Derivative Asset, Noncurrent USD 230,000 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap DerivativeLiabilities Derivative Liability USD 671,000 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 273,448 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 1.94M 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap DividendIncomeOperating Dividend Income, Operating USD 1.70M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001493152-24-044833
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 870 2023-03-31 2023 Q1 10-Q 2023-05-15 0001193125-23-145095
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -8.05 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -8.05 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.019 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.17 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent pure 0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.07 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlements Effective Income Tax Rate Reconciliation, Tax Settlement, Percent pure -0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -6,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 400,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037847
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 1.19M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 11,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 19,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 273,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 141,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 132,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 296,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 131,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 34,000 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 17,000 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 17,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 91,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 57,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 23,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 144,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.084 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD -1.62M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap GainOnSaleOfInvestments Gain on Sale of Investments USD 244,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -471,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-041122
us-gaap GrantsReceivable Grants Receivable USD 50,000 2025-06-30 2025 Q2 10-Q 2025-08-08 0001641172-25-022797
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 0 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023140
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -11.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap IncomeTaxesPaid Income Taxes Paid USD 11,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 3.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 139,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -4.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap IncomeTaxReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount USD -348,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 30,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 121,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 10,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 299,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap IncomeTaxReconciliationTaxSettlements Effective Income Tax Rate Reconciliation, Tax Settlement, Amount USD 342,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 717,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -15,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037847
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 2.57M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -366,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap IncreaseDecreaseInFairValueOfPriceRiskFairValueHedgingInstruments1 Increase (Decrease) in Fair Value of Price Risk Fair Value Hedging Instruments USD 2.70M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001493152-24-044833
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 135,870 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -851,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 1.50M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 15,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -182,168 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap InterestExpenseDebt Interest Expense, Debt USD 68,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 147,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap InterestPayableCurrent Interest Payable, Current USD 68,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1,669 2021-03-24 2021-12-31 2022 FY 10-K 2023-03-31 0001193125-23-088349
us-gaap InvestmentIncomeNonoperating Investment Income, Nonoperating USD 0 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 88,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 58,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 3,000 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2,000 2024-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 16,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 14,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap Liabilities Liabilities USD 3.89M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 5.52M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap LiabilitiesCurrent Liabilities, Current USD 3.73M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 4.58M 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 1.00M 2020-11-30 2023 Q3 10-Q 2023-11-14 0001493152-23-041122
us-gaap LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities Liquidation Basis of Accounting, Accrued Costs to Dispose of Assets and Liabilities USD 100,000 2021-09-30 2021 Q3 10-Q 2021-11-12 0001193125-21-328181
us-gaap LoansPayableCurrent Loans Payable, Current USD 1.00M 2022-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap LongTermDebt Long-term Debt USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 668,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap LongTermDebtFairValue Long-term Debt, Fair Value USD 152,000 2022-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 600,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 600,000 2024-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 600,000 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap LongTermDebtPercentageBearingVariableInterestRate Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate pure 0.24 2024-09-30 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap LongTermNotesAndLoans Notes and Loans, Noncurrent USD 2.06M 2023-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap LossContingencyDamagesPaidValue Loss Contingency, Damages Paid, Value USD 200,000 2023-11-15 2024 Q3 10-Q 2024-11-12 0001493152-24-044833
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 600,000 2023-11-15 2025 Q2 10-Q 2025-08-08 0001641172-25-022797
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 869,000 2024-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 40,834 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 434,000 2024-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 9.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -61,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -10.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -11.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -12.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 786,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap NotesPayable Notes Payable USD 2.00M 2024-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap NotesPayableCurrent Notes Payable, Current USD 1.49M 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 1.46M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001193125-23-145095
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OperatingExpenses Operating Expenses USD 12.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -12.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 83,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 53,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 30,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OperatingLeasePayments Operating Lease, Payments USD 912,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 83,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 303,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001641172-25-010317
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.08 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -9,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -22,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OtherDepreciationAndAmortization Other Depreciation and Amortization USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OtherExpenses Other Expenses USD 14,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap OtherLiabilitiesFairValueDisclosure Other Liabilities, Fair Value Disclosure USD 29.19M 2022-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.50M 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -14,000 2023-01-01 2023-03-31 2024 Q1 10-Q 2024-05-14 0001493152-24-019305
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 785,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 308,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap PaymentsForRepurchaseOfOtherEquity Payments for Repurchase of Other Equity USD 190.01M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001193125-23-088349
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 437,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.34M 2021-03-24 2021-12-31 2022 FY 10-K 2023-03-31 0001193125-23-088349
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 50,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 62,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap PaymentsToAcquireRestrictedInvestments Payments to Acquire Restricted Investments USD 1.34M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap PaymentsToEmployees Payments to Employees USD 150,000 2023-11-15 2025 Q2 10-Q 2025-08-08 0001641172-25-022797
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 570,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 636,000 2024-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-31 0001193125-23-088349
us-gaap PrepaidInsurance Prepaid Insurance USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap ProceedsFromBankDebt Proceeds from Bank Debt USD 200,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 3.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 3.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 25,000 2021-09-14 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 600,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 14.91M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 4.80M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 1.25M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 2.76M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 200,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 2.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap ProceedsFromSaleOfRestrictedInvestments Proceeds from Sale of Restricted Investments USD 622,288 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 281,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 49,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -11.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation USD 556,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation USD 347,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation USD 903,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.55M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 704,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 300,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD 144,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 7.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap RestrictedCash Restricted Cash USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 219,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037847
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 119,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023140
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 219,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -153.53M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 45,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 4.74M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 16,375 2024-04-18 2025 Q2 10-Q 2025-08-08 0001641172-25-022797
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 4.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 600,000 2022-12-31 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 450,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.872 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037847
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.044 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0.872 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023140
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap SharePrice Share Price USD/shares 20 2024-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap SharesIssued Shares, Issued shares 35.52M 2023-09-12 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap SharesOutstanding Shares, Outstanding shares 35.52M 2023-09-12 2023 FY 10-K 2024-03-15 0001493152-24-010158
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-041122
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.63M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 1.63M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.063 2026-07-27 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap StockIssued1 Stock Issued USD 311,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001493152-24-044833
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.92M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022372
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 19,773 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap StockIssuedDuringPeriodSharesStockSplits Stock Issued During Period, Shares, Stock Splits shares 79,438 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 3.07M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 9.60M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 369,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 2.20M 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037847
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 5.06M 2026-01-01 2026-03-31 2026 Q2 10-Q 2026-08-13 0001493152-26-037847
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.08M 2023-04-01 2023-06-30 2023 Q3 10-Q 2023-11-14 0001493152-23-041122
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 281,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001641172-25-001810
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD -761,142 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 43.21M 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2021-09-30 2021 Q3 10-Q 2021-11-12 0001193125-21-328181
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 40,834 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 2.36M 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2023-06-30 2023 Q2 10-Q 2023-08-21 0001193125-23-217072
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 282,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 283,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 4.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001493152-26-013242
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460940

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →